Derek Chalmers
2020
In 2020, Derek Chalmers earned a total compensation of $2.9M as President and Chief Executive Officer at Cara Therapeutics, a 15% decrease compared to previous year.
Compensation breakdown
| Bonus | $86,520 |
|---|---|
| Non-Equity Incentive Plan | $346,080 |
| Option Awards | $1,075,130 |
| Salary | $576,800 |
| Stock Awards | $818,000 |
| Other | $11,079 |
| Total | $2,913,609 |
Chalmers received $1.1M in option awards, accounting for 37% of the total pay in 2020.
Chalmers also received $86.5K in bonus, $346.1K in non-equity incentive plan, $576.8K in salary, $818K in stock awards and $11.1K in other compensation.
Rankings
In 2020, Derek Chalmers' compensation ranked 3,976th out of 13,090 executives tracked by ExecPay. In other words, Chalmers earned more than 69.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,976 out of 13,090 | 70th |
Division Manufacturing | 1,594 out of 5,621 | 72nd |
Major group Chemicals And Allied Products | 604 out of 2,254 | 73rd |
Industry group Drugs | 522 out of 1,954 | 73rd |
Industry Pharmaceutical Preparations | 396 out of 1,459 | 73rd |
Source: SEC filing on April 23, 2021.
Chalmers' colleagues
We found four more compensation records of executives who worked with Derek Chalmers at Cara Therapeutics in 2020.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019